Snapshot of antimicrobial stewardship programs in the hospitals of Pakistan: findings and implications.

Antimicrobial resistance Antimicrobial stewardship Epidemiology Infectious disease Microbiology Pakistan Public health

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 01 2019
revised: 18 05 2019
accepted: 23 07 2019
entrez: 7 8 2019
pubmed: 7 8 2019
medline: 7 8 2019
Statut: epublish

Résumé

We are unaware of the extent of antimicrobial stewardship programs (ASPs) among hospitals in Pakistan, which is a concern given the population size, high use of antibiotics across sectors and increasing antimicrobial resistance (AMR) rates. Consequently, we sought to address this by undertaking a comprehensive survey. In this cross-sectional observational study in Punjab, an instrument of the measure was developed based on health care facility characteristics and ASPs after an extensive literature review Out of 254, a total of 137 hospitals fully completed the questionnaire - 11 primary, 65 secondary, 46 tertiary and 15 specialized hospitals. The use of antimicrobial prescribing guidelines (68.7%), provision of infectious diseases consultation services (66.4%), clinical pharmacy service (65.7%), use of drug and therapeutics committees to approve antimicrobial prescribing (65.5%), regular audit by doctors on antimicrobial prescribing (54.1%) and use of a restricted formulary for antimicrobial (50.4%) were the most common ASPs. However, most of these activities were only somewhat or moderately successful. Whereas, electronic antimicrobial prescribing approval systems (15.3%), using a sticker to notify prescribers regarding the need to obtain approval for the antimicrobial prescribed (16.1%) and participation in the national antimicrobial utilization surveillance program (19.7%) were only seen in a few hospitals. Study inferred that there are inadequate ASPs in the hospitals of Pakistan. A multidisciplinary approach, clinical leadership and availability of motivated and trained individuals are essential elements for the success of future ASPs.

Identifiants

pubmed: 31384689
doi: 10.1016/j.heliyon.2019.e02159
pii: S2405-8440(19)35819-0
pii: e02159
pmc: PMC6664037
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e02159

Références

J Antimicrob Chemother. 2005 Jan;55(1):6-9
pubmed: 15531594
J Antimicrob Chemother. 2006 Jun;57(6):1197-204
pubmed: 16565158
Clin Infect Dis. 2007 Jan 15;44(2):159-77
pubmed: 17173212
J Infect Prev. 2011 Jan;12(1):6-10
pubmed: 21532974
Infect Control Hosp Epidemiol. 2012 Apr;33(4):322-7
pubmed: 22418625
Eur J Clin Microbiol Infect Dis. 2013 May;32(5):627-36
pubmed: 23224717
Virulence. 2013 Feb 15;4(2):151-7
pubmed: 23302793
PLoS Med. 2013;10(5):e1001429
pubmed: 23667342
PLoS One. 2013 Dec 09;8(12):e79747
pubmed: 24348995
Clin Microbiol Infect. 2014 Oct;20(10):963-72
pubmed: 25039787
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
Ups J Med Sci. 2016 Aug;121(3):159-64
pubmed: 27416324
Bull World Health Organ. 2016 Aug 1;94(8):558-558A
pubmed: 27516629
Int J Infect Dis. 2016 Oct;51:70-72
pubmed: 27647658
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Clin Infect Dis. 2017 Apr 15;64(8):1134-1139
pubmed: 28203781
Lancet Infect Dis. 2017 Sep;17(9):990-1001
pubmed: 28629876
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1273-1280
pubmed: 28776442
Antimicrob Resist Infect Control. 2018 Jan 26;7:15
pubmed: 29423190
Expert Rev Anti Infect Ther. 2018 May;16(5):381-384
pubmed: 29672172
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Bull World Health Organ. 2018 Apr 01;96(4):266-280
pubmed: 29695883
Lancet Infect Dis. 2018 Oct;18(10):1066-1067
pubmed: 30303099
Travel Med Infect Dis. 2019 Jan - Feb;27:127
pubmed: 30339826
Expert Rev Clin Pharmacol. 2019 Feb;12(2):159-168
pubmed: 30407089
Epidemiol Infect. 2018 Nov 16;:1-6
pubmed: 30442220
J Glob Antimicrob Resist. 2019 Jun;17:132-136
pubmed: 30557686
Int J Environ Res Public Health. 2019 May 05;16(9):
pubmed: 31060262

Auteurs

Zikria Saleem (Z)

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.
Rashid Latif College of Pharmacy, Lahore, Pakistan.

Mohamed Azmi Hassali (MA)

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.

Furqan Khurshid Hashmi (FK)

University College of Pharmacy, University of the Punjab, Lahore, Pakistan.

Brian Godman (B)

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Malaysia.
Department of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden.
Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK.
Health Economics Centre, University of Liverpool Management School, Liverpool, UK.

Zakkiudin Ahmed (Z)

Ripha Institute of Healthcare Improvement & Safety, Ripha University, Pakistan.

Classifications MeSH